Publicado em 29/01/2020

Narcolepsy is characterized by excessive daytime sleepiness and REM sleep instability. It is described as a syndrome characterized by excessive daytime sleepiness, cataplexy, sleep paralysis, hallucinations, and sleep fragmentation. Cataplexy is the sudden loss of muscle contraction, causing falls while conscious. Type 1 narcolepsy is characterized by cataplexy and/or low hypocretin levels in the cerebrospinal fluid (CSF), while type 2 narcolepsy does not include cataplexy and has normal hypocretin levels. Hypocretin is a chemical substance in the brain responsible for controlling wakefulness, awakening and appetite. In narcolepsy, there is a destruction of hypocretin-producing cells, and genetic factors like the HLA-DQB1 * 0602 gene are clearly determinant. Diagnosis is based on clinical decision and neurophysiology studies, after performing night polysomnography and multiple daytime sleep latency tests. Drug and non-drug treatments seek to control excessive daytime sleepiness and cataplexy episodes.

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support